The SSi Mantra has surpassed the 100 surgery milestone for robotic cardiac surgery SS Innovations maintains the world's only comprehensive robotic cardiac surgery program SSi Mantra used in more than 1000 procedures globally Company anticipates FDA approval in early 2025 FORT LAUDERDALE, FL, May 21, 2024 - SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery...
![SS Innovations’ SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion](https://prismmediawire.com/wp-content/uploads/2024/05/Newsroom-May-21-2024.png)